Actively Recruiting
Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
Led by Centre Hospitalier Intercommunal Creteil · Updated on 2026-04-14
11200
Participants Needed
1
Research Sites
79 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.
CONDITIONS
Official Title
Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Woman aged 25 to 65 living in Ile-De-France
- Eligible for DOCCU (not hysterectomized, not followed for a precancerous or cancerous cervical lesion)
- Declared the investigating general practitioner as treating physician (MT) practicing in the territory of a CPTS in the UPEC area
- Affiliate to a social security scheme or beneficiary of such a scheme
You will not qualify if you...
- Patient already included in a study on DOCCU
- Patient excluded from organized screening (cervical cancer, hysterectomy)
- Patient's opposition to participating in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Médecins généralistes dans le bassin de l'UPEC
Créteil, France
Actively Recruiting
Research Team
E
Emilie FERRAT
CONTACT
C
Camille JUNG
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here